CD4 and HIV-1 infection: Restoration of protective Ab responses by CD4+ T cell immunotherapy under the conditions examined advocates the consideration of similar approaches in other chronic infections, particularly when CD4+ T cell help is known to be defective, such as in HIV-1 infection.